Colls B M
N Z Med J. 1976 Dec 8;84(577):431-3.
Gestational trophoblastic malignancy, although rare, offers the clinician the opportunity of being able to cure a malignant disease with cytotoxic chemotherapy. Such an opportunity is fulfilled only when the progress of the post-molar patients is monitored and chemotherapy instituted as soon as the malignant transformation of the mole is documented. The management and treatment of nine cases is presented and discussed.
妊娠滋养细胞恶性肿瘤虽然罕见,但为临床医生提供了用细胞毒性化疗治愈恶性疾病的机会。只有当对葡萄胎后患者的病情进展进行监测,并在记录到葡萄胎发生恶性转化后立即开始化疗时,这种机会才能实现。本文介绍并讨论了9例患者的管理和治疗情况。